Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200058488Phase 4Completed
Phase 4, randomised trial of remimazolam (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Time from end of administration to complete awakening. Started Apr 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200058488.